Skip to nav Skip to content
Sam  Vafadar

Sam Vafadar, PA-C, DHSc

4.8 (168)

Specialty: Medical Oncology

Language(s): English

  • Overview

    Cancer Focus:
    Lung Cancer, Mesothelioma, Thymoma

    Sam Vafadar is a certified physician assistant (PA-C) in the Moffitt Cancer Center Department of Thoracic Oncology. He has been with Moffitt since 2014. Prior to his role in Thoracic Oncology, he practiced in community radiation oncology.In his current role, Sam provides care for patients undergoing active treatment with chemotherapy, immunotherapy, and experimental therapies under clinical trial protocols. He also evaluates patients who have completed treatment for long-term lung cancer surveillance.Since joining Moffitt, Sam has been nominated for Advanced Practice Professional (APP) of the Year several times. He is an active participant in the APP professional clinical ladder and the ethics committee. Sam completed his PA training at South University in Tampa, Florida, and earned his undergraduate degree in Biological Sciences at the University of South Florida. In 2021, he completed his Doctorate in Health Science at Nova Southeastern University.Sam is a co-investigator on multiple clinical trials and plays an active role in providing mentorship and training to prospective and current PA students. He has authored manuscripts for the Journal of the American Academy of Physician Assistants. He has been interviewed by both ABC Action News and Fox 13 regarding legislation aimed at improving prescribing authority for advanced practice professionals. He is also a member of the Florida Academy of PAs and the American Academy of PAs. He has participated in numerous advisory boards in the healthcare industry and has been a guest lecturer at South University Tampa's PA program. In 2020, he was awarded the Alumni Achievement Award from South University for his achievements.Sam hopes to continue making a positive impact on the lives of his patients, to further advocate for the PA profession, and to contribute to improvements in the healthcare system.

  • Publications

    • Vafadar S. Immunotherapy for non-small cell lung cancer. JAAPA. 2019 Sep.32(9):37-42. Pubmedid: 31460972.
    • Vafadar S. Immunotherapy for lung cancer: Targeting the PD-1 pathway. JAAPA. 2017 Jun.30(6):48-50. Pubmedid: 28538431.
  • Patient Comments

    Overall Satisfaction


    168 patients rated this provider

    The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

    Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

    Learn more about our patient satisfaction survey



    Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

    We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

    Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

    Learn more about our patient comments

    Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

    • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
    • He or she may be a researcher or other type of provider that does not see patients.
    • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.

    Learn more about our patient satisfaction survey, ratings and comments

Find a Doctor